Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-a ...

As of 2025, I've got over 10 years of researching companies. In total, throughout my investing life, I estimate that I researched (in depth) well over 1000 companies, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help me provide useful content for readers. After writing my own blog for about 3 years, I decided to switch to a value investing-focused YouTube channel, where I researched hundreds of different companies ...

In my latest analysis of Meta (NASDAQ: META ), I upgraded it to a “cautious” buy. This rating was based on a combination of factors, such as a valuation that is slightly higher than historical levels (that's why it's "cautious"), mixed with potential through better ads andEquity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Fee ...

Key Points Merck's growth potential is underrated. Novo Nordisk's sell-off has gone too far. Pfizer's story is better than meets the eye. 10 stocks we like better than Merck › The major market indexes are bumping against all-time highs. It's not surprising, therefore, that many stocks are trading at steep valuations. There are, however, some exceptions that are still bargains. Three Motley Fool contributors believe they've found dirt cheap value stocks to buy right now. Here's why they picked Me ...

I last wrote about SLM Corporation (NASDAQ: SLM ) after its 1Q25 results. I issued a neutral [HOLD] rating to the stock at that time, as I find its valuation to be quite expensive even when consideringI am a value focused investor, conducting fundamental research on sectors like but not limited to chemicals, homebuilders, building materials, industrials and metals & mining. I prefer to invest in stocks which are cheaply available and have a catalyst in the near future. My investment horizon ranges from a qu ...

公司核心业务 - CorMedix是一家生物技术公司 专注于开发和制造药物DefenCath 该药物用于减少导管相关血流感染(CRBSI) [1] 产品研发进展 - DefenCath于2023年11月15日获得美国FDA批准 [1] 股票信息 - 公司在纳斯达克上市 股票代码为CRMD [1]

Thanks to our global coverage, we've ramped up our global macro commentary on our marketplace service here on Seeking Alpha, The Value Lab . We focus on long-only value ideas, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value investor serious about protecting your wealth, we at the Value Lab might be of inspiration.The Jap ...

分析师背景与研究方法 - 采用价值投资策略 基于所有者思维和长期投资视角 [1] - 不发布做空报告 从不建议做空操作 [1] - 曾任职富达投资顾问 现为独立投资者并分享研究成果 [1] 信息披露声明 - 分析师未持有任何提及公司的股票 期权或衍生品头寸 [2] - 未来72小时内无任何头寸建立计划 [2] - 文章内容为独立研究成果 未获得相关公司报酬 [2] 平台性质说明 - 过往业绩不保证未来结果 不提供具体投资建议 [3] - 观点不代表Seeking Alpha整体立场 [3] - 平台非持牌证券交易商或投资顾问 分析师包含专业及个人投资者 [3]

Semiconductor capital equipment is notorious for its booms and busts. Few suppliers feel those swings more acutely than Ichor Holdings, Ltd. (NASDAQ: ICHR ), a niche subsystem maker that has grown rapidly through acquisitions but stillBSc (Eng), MBA. Self-taught value investor with 2 decades of investing experience. Blogger at i4value.asia. The blog is on value investing through case studies where I analyze and value listed companies in the ASEAN and US regions. I have an exceptional perspective having serv ...